301 related articles for article (PubMed ID: 20211953)
1. Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo controlled trial.
Maruyama T; Taguchi O; Niederman MS; Morser J; Kobayashi H; Kobayashi T; D'Alessandro-Gabazza C; Nakayama S; Nishikubo K; Noguchi T; Takei Y; Gabazza EC
BMJ; 2010 Mar; 340():c1004. PubMed ID: 20211953
[TBL] [Abstract][Full Text] [Related]
2. The 23-valent pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis: a double-blinded, randomized, placebo-controlled trial.
Izumi Y; Akazawa M; Akeda Y; Tohma S; Hirano F; Ideguchi H; Matsumura R; Miyamura T; Mori S; Fukui T; Iwanaga N; Jiuchi Y; Kozuru H; Tsutani H; Saisyo K; Sugiyama T; Suenaga Y; Okada Y; Katayama M; Ichikawa K; Furukawa H; Kawakami K; Oishi K; Migita K
Arthritis Res Ther; 2017 Jan; 19(1):15. PubMed ID: 28122642
[TBL] [Abstract][Full Text] [Related]
3. Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Swedish Pneumococcal Vaccination Study Group.
Ortqvist A; Hedlund J; Burman LA; Elbel E; Höfer M; Leinonen M; Lindblad I; Sundelöf B; Kalin M
Lancet; 1998 Feb; 351(9100):399-403. PubMed ID: 9482293
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial.
Cutts FT; Zaman SM; Enwere G; Jaffar S; Levine OS; Okoko JB; Oluwalana C; Vaughan A; Obaro SK; Leach A; McAdam KP; Biney E; Saaka M; Onwuchekwa U; Yallop F; Pierce NF; Greenwood BM; Adegbola RA;
Lancet; 2005 Mar 26-Apr 1; 365(9465):1139-46. PubMed ID: 15794968
[TBL] [Abstract][Full Text] [Related]
5. Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults.
Bonten MJ; Huijts SM; Bolkenbaas M; Webber C; Patterson S; Gault S; van Werkhoven CH; van Deursen AM; Sanders EA; Verheij TJ; Patton M; McDonough A; Moradoghli-Haftvani A; Smith H; Mellelieu T; Pride MW; Crowther G; Schmoele-Thoma B; Scott DA; Jansen KU; Lobatto R; Oosterman B; Visser N; Caspers E; Smorenburg A; Emini EA; Gruber WC; Grobbee DE
N Engl J Med; 2015 Mar; 372(12):1114-25. PubMed ID: 25785969
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of an 11-valent pneumococcal conjugate vaccine against radiologically confirmed pneumonia among children less than 2 years of age in the Philippines: a randomized, double-blind, placebo-controlled trial.
Lucero MG; Nohynek H; Williams G; Tallo V; Simões EA; Lupisan S; Sanvictores D; Forsyth S; Puumalainen T; Ugpo J; Lechago M; de Campo M; Abucejo-Ladesma E; Sombrero L; Nissinen A; Soininen A; Ruutu P; Riley I; Mäkelä HP
Pediatr Infect Dis J; 2009 Jun; 28(6):455-62. PubMed ID: 19483514
[TBL] [Abstract][Full Text] [Related]
7. The impact of a 9-valent pneumococcal conjugate vaccine on the public health burden of pneumonia in HIV-infected and -uninfected children.
Madhi SA; Kuwanda L; Cutland C; Klugman KP
Clin Infect Dis; 2005 May; 40(10):1511-8. PubMed ID: 15844075
[TBL] [Abstract][Full Text] [Related]
8. Rethinking results from the Japanese 23-valent pneumococcal polysaccharide vaccine randomized clinical trial.
Gessner BD; Theilacker C; Jodar L
Vaccine; 2019 Aug; 37(35):4853-4857. PubMed ID: 31327653
[TBL] [Abstract][Full Text] [Related]
9. Prevention of adult pneumococcal pneumonia with the 13-valent pneumococcal conjugate vaccine: CAPiTA, the community-acquired pneumonia immunization trial in adults.
Isturiz R; Webber C
Hum Vaccin Immunother; 2015; 11(7):1825-7. PubMed ID: 26076136
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of 23-valent pneumococcal polysaccharide vaccine in preventing community-acquired pneumonia among immunocompetent adults: A systematic review and meta-analysis of randomized trials.
Diao WQ; Shen N; Yu PX; Liu BB; He B
Vaccine; 2016 Mar; 34(13):1496-1503. PubMed ID: 26899376
[TBL] [Abstract][Full Text] [Related]
11. Vaccines for preventing pneumococcal infection in adults.
Dear K; Holden J; Andrews R; Tatham D
Cochrane Database Syst Rev; 2003; (4):CD000422. PubMed ID: 14583920
[TBL] [Abstract][Full Text] [Related]
12. A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults.
French N; Gordon SB; Mwalukomo T; White SA; Mwafulirwa G; Longwe H; Mwaiponya M; Zijlstra EE; Molyneux ME; Gilks CF
N Engl J Med; 2010 Mar; 362(9):812-22. PubMed ID: 20200385
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against community-acquired pneumonia in older individuals after the introduction of childhood 13-valent pneumococcal conjugate vaccine: A multicenter hospital-based case-control study in Japan.
Nakashima K; Suzuki K; Aoshima M; Murabata M; Kondo K; Ohfuji S; Fukushima W; Maeda A; Hirota Y;
Vaccine; 2022 Nov; 40(46):6589-6598. PubMed ID: 36184405
[TBL] [Abstract][Full Text] [Related]
14. Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease.
Walters JA; Tang JN; Poole P; Wood-Baker R
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD001390. PubMed ID: 28116747
[TBL] [Abstract][Full Text] [Related]
15. [Clinical trial of an antipneumococcal vaccine in elderly subjects living in institutions].
Gaillat J; Zmirou D; Mallaret MR; Rouhan D; Bru JP; Stahl JP; Delormas P; Micoud M
Rev Epidemiol Sante Publique; 1985; 33(6):437-44. PubMed ID: 3914014
[TBL] [Abstract][Full Text] [Related]
16. Rationale and design of CAPITA: a RCT of 13-valent conjugated pneumococcal vaccine efficacy among older adults.
Hak E; Grobbee DE; Sanders EA; Verheij TJ; Bolkenbaas M; Huijts SM; Gruber WC; Tansey S; McDonough A; Thoma B; Patterson S; van Alphen AJ; Bonten MJ
Neth J Med; 2008 Oct; 66(9):378-83. PubMed ID: 18990781
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine.
Jackson LA; Gurtman A; Rice K; Pauksens K; Greenberg RN; Jones TR; Scott DA; Emini EA; Gruber WC; Schmoele-Thoma B
Vaccine; 2013 Aug; 31(35):3585-93. PubMed ID: 23688527
[TBL] [Abstract][Full Text] [Related]
18. 23-valent pneumococcal polysaccharide vaccine improves survival in dialysis patients by preventing cardiac events.
Ihara H; Kikuchi K; Taniguchi H; Fujita S; Tsuruta Y; Kato M; Mitsuishi Y; Tajima K; Kodama Y; Takahashi F; Takahashi K; Azuma N
Vaccine; 2019 Oct; 37(43):6447-6453. PubMed ID: 31526624
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults.
Jackson LA; Gurtman A; van Cleeff M; Jansen KU; Jayawardene D; Devlin C; Scott DA; Emini EA; Gruber WC; Schmoele-Thoma B
Vaccine; 2013 Aug; 31(35):3577-84. PubMed ID: 23688526
[TBL] [Abstract][Full Text] [Related]
20. Effects of 13-valent pneumococcal conjugate vaccination of adults on lower respiratory tract infections and antibiotic use in primary care: secondary analysis of a double-blind randomized placebo-controlled study.
van Werkhoven CH; Bolkenbaas M; Huijts SM; Verheij TJM; Bonten MJM
Clin Microbiol Infect; 2021 Jul; 27(7):995-999. PubMed ID: 32971253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
